Hall, Angela M <br/><br/>
Abrogating monoacylglycerol acyltransferase activity in liver improves glucose tolerance and hepatic insulin signaling in obese mice.  [electronic resource] 

 -  Diabetes  Jul 2014 
 - 2284-96 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1939-327X 
<br/><br/><label>Standard No.: </label>10.2337/db13-1502  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acyltransferases--antagonists & inhibitors<br/>Animals<br/>Diet, High-Fat<br/>Diglycerides--metabolism<br/>Gene Expression--drug effects<br/>Glucose--metabolism<br/>Insulin--metabolism<br/>Liver--drug effects<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Obese<br/>Mice, Transgenic<br/>Obesity--etiology<br/>Oligonucleotides, Antisense--genetics<br/>Signal Transduction--drug effects<br/>Triglycerides--metabolism